Revisão
Revisado por pares
The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders
2004; Adis, Springer Healthcare; Volume: 64; Issue: 7 Linguagem: Inglês
10.2165/00003495-200464070-00004
ISSN1179-1950
AutoresRhonda Orr, Maria Fiatarone Singh,
Tópico(s)Effects and risks of endocrine disrupting chemicals
Referência(s)